Filing Details
- Accession Number:
- 0001593968-20-000862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-19 18:39:37
- Reporting Period:
- 2020-03-18
- Accepted Time:
- 2020-03-19 18:39:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887247 | Adamis Pharmaceuticals Corp | ADMP | Pharmaceutical Preparations (2834) | 820429727 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1461736 | O Robert Hopkins | C/O Adamis Pharmaceuticals Corporation 11682 El Camino Real, Ste 300 San Diego CA 92130 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-18 | 8,749 | $0.34 | 308,731 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3253 to $0.355, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, anysecurity holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
